Instruction for use: Travocort

Active substance Diflucortolone + Izoconazole

ATX code D07XC Corticosteroids with high activity in combination with other drugs

Pharmacological group

Glucocorticosteroids in combinations

Nosological classification (ICD-10)

B35 Dermatophytosis

Lishay Grubi-Saburo, Lichen microsporic, Ringworm, fine-spore, Microsporosis, Dermatomycosis of the groin area and smooth skin, Mycosis of the skin and nails, caused by Trychophyton, Microsporia, Ringworm, Trichophytia, Epidermophytia

B35.3 Mycosis of the feet

Foot fungus, Dermatophytosis of feet, Interdigital fungal erosion, Mycosis of the feet, Mycosis stop, Mycosis of feet and large folds, Epidermophytia of the feet

B35.4 Mycosis of the trunk

Dermatomycosis of the trunk, Dermatomycosis of the trunk, Skin mycosis, Mycosis of the smooth skin of the trunk, Microsporia of smooth skin, Rough smooth skin smoothing, Dermatophytosis of the trunk

B35.6 The inguinal epidermophytosis

Fungal lesions of skin folds, Dermatomycosis of the groin area and smooth skin, Mycosis of the inguinal region, Inguinal dermatophytosis, Inguinal epidermophytosis, Inguinal dermatomycosis, Mycosis of feet and large folds

B35.8 Other dermatophytosis

Rubromycosis, Rubrophytia, Genital dermatophytosis, Trichophytosis of the skin of lower extremities, Dermatomycosis of shins

B37.9 Candidiasis, unspecified

Candida albicans, Deep visceral candidiasis, Fungal infections, Fungal lesions, Candidamycosis, Candidiasis with prolonged treatment with antibacterial agents, Acute atrophic candidiasis, Monilias, Candidiasis of internal organs, Thrush

B49 Mycosis, unspecified

Common mycoses, Visceral mycosis, Deep endemic mycoses, Keratomycosis, Cutaneous mycosis, Pulmonary mycosis, Mycosis, Mycosis eyes, Mycoses of the gastrointestinal tract, Mycosis of large skin folds, Mycosis with secondary bacterial infection, Mycoses in patients with immunodeficiency, Systemic fungal infections, Tropical mycoses, Fungal infections of the skin, Fungal lesions of skin folds, Fungal infection, Fungal skin lesions, Fungal lesions of the bronchial mucosa, Fungal lesions of the oral mucosa, Infections fungal, Infections of skin fungal, Skin mycoses, Mycosis systemic, Mycosis of the mucous membranes

L08.1 Erythrasma

Erythrasm

Composition

Cream for external use 100 g

Active substances:

Diflucortolone valerate 0.1 g

Isoconazole nitrate 1 g

Auxiliary substances: polysorbate 60 - 3.5 g; Sorbitan stearate - 1 g; Cetostearyl alcohol (cetyl alcohol - 60%, stearyl alcohol - 40%) - 5 g; Paraffin liquid - 10 g; Vaseline white - 10 g; Disodium edetate 0.1 g; Purified water - 69.3 g

pharmachologic effect

Pharmacological action - anti-inflammatory, antibacterial, antifungal.

Dosing and Administration

Outwardly. For adults and children older than 2 years, Travocort® is applied a thin layer on the affected skin areas 2 times a day. In case of damage to the fingers or toes, it is recommended that a gauze pad, impregnated with cream, be laid between them. The duration of treatment should not exceed 2 weeks. If further treatment is necessary, it is possible to continue therapy with antifungal drugs without GCS (glucocorticosteroids).

Application in childhood. It is not necessary to specifically adjust the dose when using Travocort® to children aged 2 years and older or to adolescents.

Form of issue

Cream for external use, 1 mg + 10 mg. By 15 g, 20 g or 30 g in an aluminum, laminated PE tube sealed with a membrane, with a PE (polyethylene) screw cap. The tube is placed in a cardboard box.

Conditions of leave from pharmacies

On prescription.

Storage conditions

At a temperature not higher than 25 ° C.

Keep out of the reach of children.

Shelf life

5 years.

Do not use after the expiration date stated on the package